Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,350 | -10,000 | -7,410 | -4,690 | -2,380 |
| Depreciation Amortization | 170 | 760 | 600 | 430 | 210 |
| Other Working Capital | -470 | 430 | 340 | 70 | -60 |
| Other Operating Activity | 610 | 2,970 | 2,400 | 1,620 | 580 |
| Operating Cash Flow | $-2,040 | $-5,840 | $-4,070 | $-2,570 | $-1,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -20 | -20 | -20 | -20 |
| Other Investing Activity | 1,710 | -230 | -660 | 30 | -480 |
| Investing Cash Flow | $1,710 | $-250 | $-680 | $10 | $-500 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 180 | 5,810 | 4,450 | 2,160 | 1,960 |
| Financing Cash Flow | $180 | $5,810 | $4,450 | $2,160 | $1,960 |
| Beginning Cash Position | 350 | 630 | 630 | 630 | 630 |
| End Cash Position | 210 | 350 | 330 | 230 | 430 |
| Net Cash Flow | $-130 | $-280 | $-290 | $-400 | $-200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,040 | -5,840 | -4,070 | -2,570 | -1,650 |
| Free Cash Flow | -2,040 | -5,840 | -4,070 | -2,570 | -1,650 |